| Patent application number | Description | Published |
|---|
| 20100100505 | NEUTRAL PIXEL CORRECTION FOR PROPER MARKED COLOR PRINTING - A system calculates appropriate billing within an imaging pipeline. An input component receives an image that is described as a plurality of pixels. A PDL component receives the image and determines a location, a color and a designation for each of the one or more pixels. A marking engine modifies the one or more pixels based at least in part on the location and the color provided by the PDL component and places each of the one or more pixels as a monochrome or a composite pixel on a substrate. An analysis component counts the number of monochrome and composite pixels placed on the substrate by the marking engine, the number of composite pixels that include a designation are counted as monochrome. A billing component calculates the cost for placing each of the monochrome and the composite pixels counted by the analysis component. | 04-22-2010 |
| 20100232652 | System And Method For Adjusting Operation Of Printheads In An Ink Printing Device - A method evaluates image quality in an ink printing system and generates data values for altering the operation of the ink printing system. The method includes generating an ink image on an ink image receiving member that corresponds to a digital image stored in the ink printing system, generating a scanned image signal corresponding to the ink image, generating firing signal waveform adjustments and image data adjustments with reference to the scanned image signal corresponding to the ink image, and operating a printhead in an ink imaging system with reference to the firing signal waveform adjustments and the image data adjustments. | 09-16-2010 |
| 20100280929 | SYSTEM AND METHOD FOR DETERMINING A BILLING STRUCTURE FOR DOCUMENTS BASED ON COLOR AVERAGE OF MARKED COLOR PIXELS - Disclosed herein is a method and system for determining a billing structure for outputting documents using an image processing apparatus. If image data of the document includes color pixels, a billing structure is determined for each page based on an amount of color coverage. The marked color pixel locations of the image data to be output in the device dependent space are counted. Each color pixel location comprises at least one color plane. In some cases, a ratio of the count of the marked color pixel locations to a maximum number of pixel locations may be used to determine the amount on the page. Processing and determining a billing structure based on image data in the device dependent space, irrespective of the amount of ink/toner or color planes used, avoids charging a customer for color print job when only a small amount of color pixels are printed. | 11-04-2010 |
| Patent application number | Description | Published |
|---|
| 20080234269 | N-Oxo-Heterocycle and N-Oxo-Alkyl Quinoline-4-Carboxamides as Nk-3 Receptor Ligands - Compounds of Formula I | 09-25-2008 |
| 20100016283 | COMPOUNDS AND USES THEREOF - 150 - Formula (I) below: and their pharmaceutically acceptable salts or tautomers, compositions and methods of use thereof. These novel compounds provide a treatment or prophylaxis of at least one symptom or condition associated with schizophrenia and other psychotic disorders, dementia and other cognitive disorders, anxiety disorders, mood disorders, sleep disorders, disorders usually first diagnosed in infancy, childhood, or adolescence and neurodegenerative disorders. | 01-21-2010 |
| 20100016284 | COMPOUNDS AND USES THEREOF - 151 - This invention relates to novel compounds having the structural Formula I below: and their pharmaceutically acceptable salts or tautomers, compositions and methods of use thereof. These novel compounds provide a treatment or prophylaxis of at least one symptom or condition associated with schizophrenia and other psychotic disorders, dementia and other cognitive disorders, anxiety disorders, mood disorders, sleep disorders, disorders usually first diagnosed in infancy, childhood, or adolescence and neurodegenerative disorders. | 01-21-2010 |
| 20100056492 | COMPOUNDS AND USES THEREOF - 152 - This invention relates to novel compounds having the structural Formula (I) below: and their pharmaceutically acceptable salts or tautomers, compositions and methods of use thereof. These novel compounds provide a treatment or prophylaxis of at least one symptom or condition associated with schizophrenia and other psychotic disorders, dementia and other cognitive disorders, anxiety disorders, mood disorders, sleep disorders, disorders usually first diagnosed in infancy, childhood, or adolescence and neurodegenerative disorders. | 03-04-2010 |
| 20100093699 | COMPOUNDS AND USES THEREOF - 177 - This invention relates to novel compounds having the structural Formula (I) below: and their pharmaceutically acceptable salts, compositions and methods of use thereof. These novel compounds provide a treatment or prophylaxis of at least one symptom or condition associated with schizophrenia and other psychotic disorders, dementia and other cognitive disorders, anxiety disorders, mood disorders, sleep disorders, disorders usually first diagnosed in infancy, childhood, or adolescence, and neurodegenerative disorders. | 04-15-2010 |
